Inhibition of SIRT1 Increases EZH2 Protein Level and Enhances the Repression of EZH2 on Target Gene Expression

doi:10.1016/S1001-9294(11)60024-2

摘要/Abstract

摘要： Objective To study the regulatory rolesof SIRT1 on EZH2 expression and the further effects on EZH 2’ s repression of target gene expression.Methods The stable SIRT1 RNAi and Control RNAi HeLa cells were established by infection with retroviruses expressing shSIRT1 and shLuc respectively followed by puromycin selection. EZH2 protein level was detected by Western blot in either whole cell lysate or the fractional cell extract. Reverse transcription-polymerase chain reaction was performed to detect the mRNA level of EZH2. Cycloheximide was used to treat SIRT1 RNAi and Control RNAi cells for protein stability assay. Chromatin immunoprecipitation(ChIP) assay was applied to measure enrichment of SIRT1, EZH2, and trimethylated H3K27 (H3K27me3) at SATB1 promoter in SIRT1 RNAi and Control RNAi cells.Results Western blot results showed that EZH2 protein level increased upon SIRT1 depletion. Fractional extraction results showed unchanged cytoplasmic fraction and increased chromatin fraction of EZH2 protein in SIRT1 RNAi cells. The mRNA level of EZH2 was not affected by knockdown of SIRT1. SIRT1 recruitment was not detected at the promoter regionof EZH2 gene locus. The protein stability assay showed that the protein stability of EZH2 increases upon SIRT1 knockdown. Upon SIRT1 depletion, EZH2 and H3K27me3 recruitment at SATB1 promoter increases and the mRNA level of SATB1 decreases. Conclusions Depletion of SIRT1 increases the protein stability of EZH2. The regulation of EZH2 protein level by SIRT1 affects the repressive effects of EZH2 on the target gene expression.

关键词: SIRT1, EZH2, Polycomb repression complex, trimethylated H3K27

Abstract: Objective To study the regulatory rolesof SIRT1 on EZH2 expression and the further effects on EZH 2’ s repression of target gene expression.Methods The stable SIRT1 RNAi and Control RNAi HeLa cells were established by infection with retroviruses expressing shSIRT1 and shLuc respectively followed by puromycin selection. EZH2 protein level was detected by Western blot in either whole cell lysate or the fractional cell extract. Reverse transcription-polymerase chain reaction was performed to detect the mRNA level of EZH2. Cycloheximide was used to treat SIRT1 RNAi and Control RNAi cells for protein stability assay. Chromatin immunoprecipitation(ChIP) assay was applied to measure enrichment of SIRT1, EZH2, and trimethylated H3K27 (H3K27me3) at SATB1 promoter in SIRT1 RNAi and Control RNAi cells.Results Western blot results showed that EZH2 protein level increased upon SIRT1 depletion. Fractional extraction results showed unchanged cytoplasmic fraction and increased chromatin fraction of EZH2 protein in SIRT1 RNAi cells. The mRNA level of EZH2 was not affected by knockdown of SIRT1. SIRT1 recruitment was not detected at the promoter regionof EZH2 gene locus. The protein stability assay showed that the protein stability of EZH2 increases upon SIRT1 knockdown. Upon SIRT1 depletion, EZH2 and H3K27me3 recruitment at SATB1 promoter increases and the mRNA level of SATB1 decreases. Conclusions Depletion of SIRT1 increases the protein stability of EZH2. The regulation of EZH2 protein level by SIRT1 affects the repressive effects of EZH2 on the target gene expression.

Key words: SIRT1, EZH2, Polycomb repression complex, trimethylated H3K27

Lu Lu, Lei Li, Xiang Lv, Xue-song Wu, De-pei Liu*, and Chih-chuan Liang. Inhibition of SIRT1 Increases EZH2 Protein Level and Enhances the Repression of EZH2 on Target Gene Expression[J].Chinese Medical Sciences Journal, 2011, 26(2): 77-84.

参考文献 33

1.	KennisonJA. The Polycomb and trithorax group proteins of Drosophila: trans-regulatorsof homeotic gene function . Annu RevGenet 1995; 29:289-303.
2.	BrackenAP, Dietrich N, Pasini D, et al. Genome-wide mapping of Polycomb target genesunravels their roles in cell fate transitions . Genes Dev 2006; 20:1123-36.
3.	SchwartzYB, Kahn TG, Nix DA, et al. Genome-wide analysis of Polycomb targets inDrosophila melanogaster . Nat Genet2006; 38:700-5.
4.	Boyer LA,Plath K, Zeitlinger J, et al. Polycomb complexes repress developmentalregulators in murine embryonic stem cells .Nature 2006; 441:349-53.
5.	Czermin B,Melfi R, McCabe D, et al. Drosophila enhancer of Zeste/ESC complexes have ahistone H3 methyltransferase activity that marks chromosomal Polycomb sites . Cell 2002; 111:185-96.
6.	M黮ler J,Hart CM, Francis NJ, et al. Histone methyltransferase activity of a DrosophilaPolycomb group re- pressor complex .Cell 2002; 111:197-208.
7.	KuzmichevA, Nishioka K, Erdjument-Bromage H, et al. Histone methyltransferase activityassociated with a human multiprotein complex containing the Enhancer of Zesteprotein . Genes Dev 2002; 16:2893-905.
8.	Cao R , Wang L, Wang H, et al. Role of histone H3 lysine 27methylation in Polycomb-group silencing .Science 2002; 298:1039-43.
9.	Pasini D,Bracken AP, Jensen MR, et al. Suz12 is essential for mouse development and forEZH2 histone methyltransferase activity .EMBO J 2004; 23:4061-71.
10	Simon JA,Lange CA. Roles of the EZH2 histone methyltransferase in cancer epigenetics . Mutat Res 2008; 647:21-9.
11	Mills AA.Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins . Nat Rev Cancer 2010; 10:669-82.
12	BrackenAP, Pasini D, Capra M, et al. EZH2 isdownstream of the pRB-E 2F pathway, essential for proliferation and amplified in cancer . EMBO J 2003; 22:5323-35.
13	Bohrer LR,Chen S, Hallstrom TC, et al. Androgens suppress EZH2 expression viaretinoblastoma (RB) and p130-dependent pathways: a potential mechanism ofandrogen-refractory progression of prostate cancer . Endocrinology 2010; 151:5136-45.
14	VaramballyS,Cao Q , Mani RS,et al. Genomic loss of microRNA-101 leads to overexpression of histone methy- ltransferaseEZH 2 incancer . Science 2008; 322:1695-9.
15	CiarapicaR, Russo G, Verginelli F, et al. Deregulated expression of miR -26aand Ezh 2 inrhabdomyosarcoma .Cell Cycle 2009; 8:172-5.
16	Juan AH,Kumar RM, Marx JG, et al. Mir-214-dependent regulation of the polycomb proteinEzh 2 inskeletal muscle andembryonic stem cells . Mol Cell 2009;36:61-74.
17	KislioukT, Yosefi S, Meiri N. MiR-138 inhibits EZH2 methyltransferase expression andmethylation of histone H3 at lysine 27, and affects thermotolerance acquisition . Eur J Neurosci 2011; 33:224-35.
18	Tan J,Yang X, Zhuang L, et al. Pharmacologic disruption of Polycomb-repressivecomplex 2-mediated gene repression selectively induces apoptosis in cancercells . Genes Dev 2007; 21:1050-63.
19	Dimri M,Bommi PV, Sahasrabuddhem AA, et al. Dietary omega-3 polyunsaturated fatty acidssuppress expression of EZH 2 in breast cancer cells . Carcinogenesis2010; 31:489-95.
20	Fiskus W,Pranpat M, Balasis M, et al. Histone deacetylase inhibitors deplete enhancer ofzeste 2 and associated polycomb repressive complex 2 proteins in human acuteleukemia cells . Mol Cancer Ther 2006;5:3096-104.
21	Haigis MC,Sinclair DA. Mammalian sirtuins: biological insights and disease relevance . Annu Rev Pathol 2010; 5:253-95.
22	KuzmichevA, Margueron R, Vaquero A, et al. Composition and histone substrates ofpolycomb repressive group complexes change during cellular differentiation . Proc Natl Acad Sci U S A 2005;102:1859-64.
23	Li L, LuL, L? X, et al. Epigenetic repression of SATB1 by Polycomb group protein EZH 2 inepithelial cells . Chin Med Sci J 2010; 25:199-205.
24	Vaziri H, Dessain SK,Ng Eaton E, et al. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase . Cell 2001; 107:149-59.
25	Brunet A,Sweeney LB, Sturgill JF, et al. Stress-dependent regulation of FOXOtranscription factors by the SIRT1 deacetylase . Science 2004; 303:2011-5.
26	Chen WY, Wang DH, Yen RC, et al. Tumor suppressor HIC1 directlyregulates SIRT1 to modulate p53-dependent DNA-damage responses . Cell 2005; 123:437-48.
27	Wang C,Chen L, Hou X, et al. Interactions between E 2F 1 and SirT1 regulate apoptotic response to DNAdamage . Nat Cell Biol 2006;8:1025-31.
28	Vaquero A,Scher M, Erdjument-Bromage H, et al. SIRT1 regulates the histonemethyl-transferase SUV39H1 during heterochromatin formation . Nature 2007; 450:440-4.
29	Vaquero A,Scher M, Lee D, et al. Human SirT1 interacts with histone H1 and promotesformation of facultative heterochromatin .Mol Cell 2004; 16:93-105.
30	Kurdistani SK, Tavazoie S, Grunstein M. Mapping global histoneacetylation patterns to gene expression .Cell 2004; 117:721-33.
31	Pruitt K,Zinn RL, Ohm JE, et al. Inhibition of SIRT1 reactivates silenced cancer geneswithout loss of promoter DNA hypermethylation . PLoS Genet 2006; 2:e40.
32	Wang RH,Sengupta K, Li C, et al. Impaired DNA damage response, genome instability, andtumorigenesis in SIRT1 mutant mice .Cancer Cell 2008; 14:312-23.
33	Deng CX.SIRT1, is it a tumor promoter or tumor suppressor? Int J Biol Sci 2009;5:147-52.

优先出版

当期目次

过刊浏览

虚拟专题

作者中心

评阅者中心